A deficient dopamine D 2 receptor (DA2) formation or action may contribute to hypertension via an increase of catecholamine release. In addition, Axis II personality disorders that appears odd or eccentric (cluster A) is associated with a low density of DA2. This study sought to examine if a NcoI restriction fragment length polymorphism (C to T transition) in exon 6 of the dopamine D 2 receptor gene (DRD2) was associated with these characteristics. The genotypes (CC, CT and TT) were compared in anthropometric, endocrine, metabolic and haemodynamic variables as well as estimates of personality disorders in 284 randomly selected 51-year-old men. Homozygotes for the C allele constituted 49% of the men and homozygotes for the T allele 9%, while heterozygotes were 41%. The TT genotype was associated with elevated systolic and diastolic blood pressure,
Introduction
The dopaminergic system exerts a variety of effects in both the brain and periphery. The classification of dopamine receptors into two categories has been modified with identification of three additional receptors. A majority of these receptors is found in the basal ganglia and the median eminence, and is involved in the control of locomotion, cognition, appetite and neuroendocrine secretion. The peripheral dopaminergic system is implicated in hormone secretion, sodium homeostasis, vascular tone, and nor adrenaline release from nerve endings. The dopamine D 1 receptor (DA1) mediates a decrease in independent of obesity and endocrine abnormalities, including the hypothalamic-pituitary-adrenal axis regulation. Moreover, the TT genotype was significantly more frequent among subjects with grade 1 (mild) hypertension (Ͼ140/90 mm Hg) compared to normotensive subjects (Ͻ130/85 mm Hg). The polymorphism in exon 6 of the DRD2 was also significantly associated with cluster A personality disorders. These results suggest that a polymorphism in exon 6 of the DRD2 examined with the restriction enzyme NcoI is associated with an elevated blood pressure, independent of obesity. Paranoid or schizoid personality disorders is also associated with a polymorphism of the DRD2, which might be associated with a previously demonstrated low density of this receptor.
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the renal sodium reabsorption. 1 A deficient DA1 response to salt loading may play an etiologic role in patients with the salt-sensitive form of hypertension. 2 An early, hyperkinetic stage of hypertension is currently believed to originate from an increased sympathetic nervous system activity. 3 Since the dopamine D 2 receptor (DA2) reduces the nor adrenaline release from sympathetic nerve endings, 1 a defect DA2 may contribute to the pathogenesis of primary hypertension. DA2-like receptors have previously been described to be associated with hypertension. 4, 5 In neuropsychiatry, schizoid personality disorders, schizophrenia and Parkinson's disease show associations with dopamine production and receptor malfunction. [6] [7] [8] [9] [10] Furthermore, the dopaminergic system seems to play a role in the development of obesity, presumably via regulation of food intake. 6, [11] [12] [13] We have recently reported that the
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Diagnostic and Statistical Manual of Mental Disorders (DSM)-IV Axis II cluster B and cluster C personality disorders 14 are associated with abdominal obesity, accompanied by a relative resistance to cortisol feedback inhibition of the hypothalamicpituitary-adrenal (HPA) axis. 15 Such associations have also been disclosed in a general population. 16 In cluster A personality disorders, however, abdominal obesity was present without evidence of a poor feedback control of the HPA axis. 15 Cluster A includes paranoid, schizoid, and schizotypal personality disorders. 17 Some but not all studies show that such personality characteristics are associated with a low density of DA2, providing empirical biologic correlates of schizophrenia. 9, 18, 19 Therefore, the aim of this study was to examine a common intragenic polymorphism in a coding region of the dopamine D 2 receptor gene (DRD2) in relation to blood pressure as well as estimates of personality disorders. Anthropometric, endocrine and metabolic variables, frequently associated with hypertension, were also measured. We hypothesised that a defect DA2 may cause elevated blood pressure via a deficient inhibition of the catecholamine release. Furthermore, such a defect DA2 might also be associated with cluster A personality disorders.
Materials and methods

Subjects
A sample of men (n = 1302) all born during the first 6 months of 1944 and living in Gö teborg were recruited in 1992 from the National Population Registry in Gö teborg, Sweden. [20] [21] [22] A total of 1040 men (80%) responded to questionnaires. [20] [21] [22] Among self-reported anthropometric measurements three subgroups among the lowest (р0.885), median (0.94 -0.96) and highest (у1.01) waist-to-hip ratio (WHR), 150 in each case, were selected. They were invited to a health examination in 1995 and 284 (63%) volunteered to participate. Among the men examined, eight were treated with angiotensin converting enzyme inhibitors and 25 with ␤-adrenergic antagonists or calcium-channel blockers. Six men had Type 2 diabetes. Further details have been reported previously. 16 None was excluded. Nine subjects refused to be involved in the genetic studies, and in 12 subjects the amount of blood samples was not sufficient to conduct genetic analysis. All men gave written informed consent before participating in the study, which was approved by the Gö teborg University Ethics Committee.
Study design
Except for salivary cortisol measurements, all examinations were performed in an overnight fasting state at the laboratory.
Anthropometry: Body weight was measured to the nearest 0.1 kg with the participants in underwear, and height to the nearest cm. The body mass index (BMI) was calculated (kg/height 2 ). The waist circumference (W) was measured half way between the lowest rib and the iliac crest, and the hip circumference (H) over the trochanter, and the WHR calculated. The abdominal sagittal diameter (ASD, cm) was determined as the distance between the examination table and the highest point of the abdomen in the recumbent position. This provides an approximation of intra-abdominal visceral fat mass. 23 Salivary cortisol measurements: These methods have been described in detail previously 16 and are summarised here briefly. Salivary cortisol was sampled repeatedly over an ordinary working day to allow estimates of morning and total cortisol secretion, as well as cortisol secretion after a standardised lunch. An overnight low-dose (0.5 mg) dexamethasone suppression test was also performed at home. 16 Hormones, glucose, lipids and blood pressure: Total serum testosterone was measured by non-extraction radioimmunoassay (RIA) (ICN Biomedicals, Costa Measa, CA, USA). Insulin-like growth factor 1, leptin and insulin were also determined with commercial RIA kits, the former after hydrochloride acid-ethanol extraction (Nichols Institute Diagnostics, San Juan Capistrano, CA, USA; Linco Research, St. Charles, MO, USA; Pharmacia Insulin RIA 100, Kabi Pharmacia Diagnostics, Uppsala, Sweden). Glucose was determined enzymatically 24 and lipids as described in Wiklund et al. 25 Blood pressure was measured twice on the right arm with the participants sitting, using a random-zero mercury sphygmomanometer, with a 5-min rest for the subject before and between readings, and with the auscultation site at heart-level, a peak inflation level of 30 mm Hg above radial pulse disappearance, a cuffdeflation rate of 2-3 mm Hg per second and pressure value recorded to the nearest even digit. The heart rate was recorded simultaneously, and the individual mean systolic and diastolic blood pressures were calculated as the mean of the two measurements.
Personality variables: A modified version of the Structured Clinical Interview for DSM (SCID) II
Screen Questionnaire was used to evaluate personality disorders. This questionnaire includes 124 questions to be answered yes or no and reflects DSM-IV, Axis II criteria for the diagnosis of cluster A (paranoid, schizoid, schizotypal), cluster B (antisocial, borderline, histrionic, narcissistic) and cluster C (avoidant, dependent, obsessive compulsive, passive aggressive) personality disorders. The questions concerning antisocial behaviour were excluded due to their offensive character in order to avoid defect or hostile responses. The original SCID II Screen questionnaire 14 does not include the questions regarding antisocial personality disorders compared to the translated and modified version used in this study. One additional criterion was added as described in Ekselius et al. 14 Determination of the genotypes: DNA was purified from blood samples using QIAamp Kit (Qiagen, Mississauga, Canada). The primers used were 5Ј-CAT GCC TCA GTG ACA T-3Ј (forward) and 5Ј-ATT GTC CGG CTT TAC C-3Ј (reverse). 26 One
26
Statistical analysis
Spjotvoll-Stoline post hoc tests 27 were performed to test the statistical significance of the differences among the mean scores of two or more groups. Blood pressure variables were adjusted for BMI, WHR, insulin and cortisol. Pearson chi-square test analysed categorical data. P values are two-sided throughout, and a P Ͻ 0.05 was considered to be significant. The statistical analyses were performed with SPSS for Windows, release 9.0 (SPSS Inc., Chicago, IL, USA).
Results
Homozygotes for the C allele constituted 49% of the men and homozygotes for the T allele 9%, while heterozygotes were 41% (Table 1) . Table 1 also shows the phenotypic characteristics of the NcoI DRD2 genotypes. In comparing the homozygotes for the C allele and the T allele, the latter had significantly higher diastolic blood pressure. Homozygotes for the T allele had also significantly higher systolic and diastolic blood pressures than the heterozygotes, while there were no differences between heterozygotes and the C allele homozygotes. When adjusted for anthropometric and endocrine variables the results remained unchanged. In addition, different inheritance modes for blood pressure were analysed, ie, dominant (CC vs CT+TT) and recessive (CC+CT vs TT) inheritance. Both systolic and diastolic blood pressures were associated with a recessive pattern of inheritance (P = 0.063 and P = 0.004 respectively) (not shown). Other measurements, including BMI, WHR and ASD, were not statistically significantly different
Journal of Human Hypertension between genotypes. This was also the case for the various measurements of cortisol secretion (not shown in the table). Table 2 shows the distribution of the NcoI DRD2 genotypes and allele frequency in normotensive (Ͻ130/85 mm Hg) and grade 1 (mild) hypertensive (Ͼ140/90 mm Hg) subjects. 28 The TT genotype was significantly (P = 0.019) more frequent among hypertensive subjects, while the allele frequency was similar in both groups. Table 3 shows the distribution of the NcoI DRD2 genotypes and allele frequency in controls and subjects with cluster A personality disorders. Men with cluster A personality disorders were more often homozygotes for the T allele (P = 0.035) in comparison with controls. Allele frequency was not different between both groups. Similar analyses with cluster B and cluster C yielded no significant differences (not shown).
Discussion
The major findings of the present study are that homozygotes for the T allele had higher blood pressure and more frequently cluster A personality disorders compared to other NcoI DRD2 alleles. The differences in blood pressure were considerable, amounting to 9.4/7.3 mm Hg systolic/diastolic blood pressure in comparison with the heterozygotes, and 6.0/6.0 mm Hg in comparison with homozygotes for the C allele, and was independent of anthropometric and endocrine variables. Moreover, the variances accounted for in systolic and diastolic blood pressure by the DRD2 genotypes were 2.5% and 3.3% respectively. Cluster A personalities seemed to have a significantly different distribution of the NcoI DRD2 genotypes than controls, although caution is warranted due to small numbers. This suggests that the DRD2 polymorphism is potentially associated with this category of personality disorders.
Evidence of diminished dopamine excretion in hypertensive subjects was first recognised some 30 years ago. 29 Specific dopaminergic receptors, distinct from the classic ␣-and ␤-adrenergic receptors, are present in the central and peripheral nervous system and in several nonneural tissues. 1 The nature of the peripheral dopaminergic system is complex, but the existence of a dopaminergic system in those tissues that respond uniquely to dopamine seems likely. 1 Because stimulation of DA1 promotes natriuresis and lowers blood pressure in humans, an involvement of the DA1 has been implicated in a potential pathogenetic role in patients with the saltsensitive form of hypertension.
1,2 However, direct conclusive evidence remains lacking.
1,2 The DA2 inhibits the transmission in sympathetic ganglia, reduces noradrenaline release from sympathetic nerve terminals and the adrenals, and inhibits aldosterone secretion from the adrenal cortex. 30, 31 In humans, the DA2s have been found in the zona glomerulosa of the adrenals, 32 and administration of
Journal of Human Hypertension 6.4 ± 4.7 5.7 ± 3.6 6.9 ± 5.4 antidopaminergic agents increases the catecholamine release. 33, 34 The DA2 has recently been implicated to be involved in the pathogenesis of hypertension, but studies in humans are scarce. 4, 5 A currently prevailing opinion is that the origin of primary hypertension might be through central neuroendocrine pathways. An increasing body of evidence suggests that the sympathetic nervous system is involved in the early, hyperkinetic phase of hypertension. 3 A dysfunctional DA2 may hypothetically amplify such elevated activity of the sympathetic nervous system. The polymorphism of the DRD2 described herein may be indicative of a defect receptor function. This possibility seems to be of sufficient interest to encourage further studies.
Hypertension is frequently found in obesity and its associated endocrine and metabolic abnormalities. 16 These relationships were, however, absent in the blood pressure elevation associated with the polymorphism of the DRD2, suggesting a pathogenetic pathway different from that seen in obesity.
We have previously shown that men with cluster A and cluster B personality disorders are obese with a disproportionately large fraction of fat localised in the abdominal area, as measured with the WHR or ASD. 15 This was not found among the various genotypes of the DRD2, suggesting that the NcoI polymorphism is not associated with abdominal obesity neither in these three personality subgroups, nor in the total material (Table 1) .
A report has suggested that a polymorphic DRD2, identified with TaqI, might be associated with obesity. 11 Although the carriers of the A1 allele showed no associations with BMI, WHR or cardiovascular risk factors, the A1 allele was more frequent in those with parental history of obesity, adult onset of obesity and carbohydrate preference in food intake. We did not measure these variables in the present study. It is therefore not possible to verify whether the genotypes, revealed by the restriction enzymes NcoI and TaqI, exhibit the same or a different relationship to obesity.
Abdominal obesity is frequently associated with a hyperactivity of the HPA axis, presumably as a result of an impaired cortisol feedback inhibition via the glucocorticoid receptor, 16 associated with DNA sequence variation at the receptor gene locus. 35 However, this does not apply to men with cluster A personality disorders, where abdominal obesity is present even when the function of the HPA axis is intact. 15 In addition, the DRD2 polymorphism examined here was not associated with abnormal functions of the HPA axis. These findings suggest that the abdominal obesity in cluster A personality disorders may have another origin than perturbations in the HPA axis or the dopaminergic system.
In summary, a polymorphism in exon 6 of the DRD2 examined with the restriction enzyme NcoI is associated with an elevated blood pressure, independent of obesity and endocrine variables. The DA2 suppresses catecholamine release at sympathetic nerve terminals, and a deficient DA2 function might tentatively contribute to the pathogenesis of primary (essential) hypertension, which in early, hyperkinetic stages is induced by hyperactivity in the sympathetic nervous system. The cluster A personality disorders is also associated with a polymorphism of the DRD2, which might be associated with a previously demonstrated low density of this receptor.
